237 related articles for article (PubMed ID: 24552080)
1. The success of the citizen suit: protecting consumers from inaccurate food labeling by amending the Federal Food, Drug, and Cosmetic Act.
Springer J
Food Drug Law J; 2013; 68(4):401-22, i-ii. PubMed ID: 24552080
[TBL] [Abstract][Full Text] [Related]
2. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
3. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
Saldanha LG
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
[TBL] [Abstract][Full Text] [Related]
4. Marketing nutrition & health-related benefits of food & beverage products: enforcement, litigation & liability issues.
Roller S; Pippins R
Food Drug Law J; 2010; 65(3):447-69, i. PubMed ID: 24479235
[TBL] [Abstract][Full Text] [Related]
5. Infant formula record and record retention requirements--FDA. Final rule.
Fed Regist; 1991 Dec; 56(247):66566-73. PubMed ID: 10116071
[TBL] [Abstract][Full Text] [Related]
6. [State surveillance and control of food quality and safety in USA].
Berman VA
Vopr Pitan; 2003; 72(2):22-7. PubMed ID: 12924205
[TBL] [Abstract][Full Text] [Related]
7. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
8. Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.
Sayeed SA
Pediatrics; 2005 Oct; 116(4):e576-85. PubMed ID: 16199687
[TBL] [Abstract][Full Text] [Related]
9. Unapproved drugs in the United States and the Food and Drug Administration.
Nasr A; Lauterio TJ; Davis MW
Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470
[TBL] [Abstract][Full Text] [Related]
10. Health-benefit claims for probiotic products.
Heimbach JT
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
[TBL] [Abstract][Full Text] [Related]
11. FDA perspectives on health claims for food labels.
Rowlands JC; Hoadley JE
Toxicology; 2006 Apr; 221(1):35-43. PubMed ID: 16480811
[TBL] [Abstract][Full Text] [Related]
12. Food labeling: nutrient content claims, expansion of the nutrient content claim "lean". Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Jan; 72(8):1455-9. PubMed ID: 17294560
[TBL] [Abstract][Full Text] [Related]
13. Food allergen law and the Food Allergen Labeling and Consumer Protection Act of 2004: falling short of true protection for food allergy sufferers.
Roses JB
Food Drug Law J; 2011; 66(2):225-42, ii. PubMed ID: 24505841
[TBL] [Abstract][Full Text] [Related]
14. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
Murdey J
Food Drug Law J; 2011; 66(1):85-104, ii-iii. PubMed ID: 24505848
[TBL] [Abstract][Full Text] [Related]
15. Safety standards in infant nutrition: a United States perspective.
Bier DM
Ann Nutr Metab; 2012; 60(3):192-5. PubMed ID: 22699766
[TBL] [Abstract][Full Text] [Related]
16. Food labeling; nutrition labeling of standard menu items in restaurants and similar retail food establishments. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Dec; 79(230):71155-259. PubMed ID: 25438344
[TBL] [Abstract][Full Text] [Related]
17. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
18. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
McNamara SH
Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
[No Abstract] [Full Text] [Related]
19. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
Lietzan E
J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
[TBL] [Abstract][Full Text] [Related]
20. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
Fed Regist; 1997 Dec; 62(239):65384-8. PubMed ID: 10176832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
